Gene implicated in lens development identified

Article

A gene that controls the development of the eye's lens, Six3, has been discovered by researchers at St Jude Children's Research Hospital, Memphis, USA.

A gene that controls the development of the eye's lens, Six3, has been discovered by researchers at St Jude Children's Research Hospital, Memphis, USA.

The gene, discovered in mouse models, is one of the earliest critical regulators that control development of the lens. The researchers found that Six3 normally exerts its effect by directly activating Pax6, a gene considered to be the master regulator of the eye, but mutations of Six3 could disrupt lens development.

Investigators previously discovered that mutations in Six3 have been identified in patients with holoprosencephaly, a disease that can cause the cerebrum to fail to divide into two lobes.

It is thought that this new information may help in forming strategies to prevent or treat disease caused by disruption of Six3 function.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
© 2025 MJH Life Sciences

All rights reserved.